Warning: The NCBI web site requires JavaScript to function. more...
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity.
Pauli EK, Schmolke M, Hofmann H, Ehrhardt C, Flory E, Münk C, Ludwig S.
Retrovirology. 2009 Apr 16;6:38.
Related citations
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression.
Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, Bode JG, Ludwig S.
PLoS Pathog. 2008 Nov;4(11):e1000196. Epub 2008 Nov 7.
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
Holmes RK, Koning FA, Bishop KN, Malim MH.
J Biol Chem. 2007 Jan 26;282(4):2587-95. Epub 2006 Nov 22.
Apobec 3F and apobec 3G have no inhibition and hypermutation effect on the human influenza A virus.
Wang GF, Lin SY, Zhang H, Gao YL, Li WZ, Xin G, Li KS.
Acta Virol. 2008;52(3):193-4. No abstract available.
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN, Holmes RK, Malim MH.
J Virol. 2006 Sep;80(17):8450-8.
Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.
Di Trani L, Savarino A, Campitelli L, Norelli S, Puzelli S, D'Ostilio D, Vignolo E, Donatelli I, Cassone A.
Virol J. 2007 May 3;4:39.
Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy.
Ludwig S, Planz O.
Biol Chem. 2008 Oct;389(10):1307-12. Review.
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.
Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S.
Cell Microbiol. 2007 Jul;9(7):1683-94. Epub 2007 Feb 23.
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
Zennou V, Bieniasz PD.
Virology. 2006 May 25;349(1):31-40. Epub 2006 Feb 7.
APOBEC-mediated interference with hepadnavirus production.
Rösler C, Köck J, Kann M, Malim MH, Blum HE, Baumert TF, von Weizsäcker F.
Hepatology. 2005 Aug;42(2):301-9.
Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH.
Curr Biol. 2004 Aug 10;14(15):1392-6.
Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
Yamada K, Ogawa H, Hara A, Yoshida Y, Yonezawa Y, Karibe K, Nghia VB, Yoshimura H, Yamamoto Y, Yamada M, Nakamura K, Imai K.
Antiviral Res. 2009 Jul;83(1):35-44. Epub 2009 Mar 24.
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
Izumi T, Shirakawa K, Takaori-Kondo A.
Mini Rev Med Chem. 2008 Mar;8(3):231-8. Review.
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
Giannecchini S, Wise HM, Digard P, Clausi V, Del Poggetto E, Vesco L, Puzelli S, Donatelli I, Azzi A.
Antiviral Res. 2011 Oct;92(1):64-72. Epub 2011 Jun 29.
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R, Spadari S, Maga G.
Med Sci Monit. 2006 May;12(5):RA92-8. Review.
Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique.
Kim MJ, Latham AG, Krug RM.
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10096-101. Epub 2002 Jul 11.
The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.
Dudek SE, Luig C, Pauli EK, Schubert U, Ludwig S.
J Virol. 2010 Sep;84(18):9439-51. Epub 2010 Jun 30.
Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral.
Dimmock NJ, Rainsford EW, Scott PD, Marriott AC.
J Virol. 2008 Sep;82(17):8570-8. Epub 2008 Jun 25.
[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B, Cen S, Jiang JD.
Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.
Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.
Miyagi E, Opi S, Takeuchi H, Khan M, Goila-Gaur R, Kao S, Strebel K.
J Virol. 2007 Dec;81(24):13346-53. Epub 2007 Oct 10.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on